IN VITRO AZACITIDINE TREATMENT MODIFIES THE PROTEOME OF AML1/ETO POSITIVE LEUKEMIA CELLS

被引：0
|
作者：
Buchi, F. [1 ]
Ferrari, G. [1 ]
Spinelli, E. [1 ]
Gozzini, A. [1 ]
Bosi, A. [1 ]
Lunghi, T. [1 ]
Santini, V [1 ]
机构：
[1] Univ Firenze, AOU Careggi, Florence, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P119
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [31] Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia
    Yin, Zhao
    Yao, Zurong
    Chen, Dandan
    Zhang, Yu
    Weng, Guangyang
    Du, Xin
    Lin, Dongjun
    Xiao, Jie
    Sun, Zhiqiang
    Zhang, Hongyu
    Liang, Xinquan
    Guo, Ziwen
    Zhao, Weihua
    Xuan, Li
    Jiang, Xuejie
    Shi, Pengcheng
    Liu, Qifa
    Ping, Baohong
    Yu, Guopan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (07)
  • [32] Increased expression of amyloid precursor protein promotes proliferation and migration of AML1/ETO-positive leukemia cells and can be inhibited by panobinostat
    Wang, C. L.
    Ding, B. J.
    Jiang, L.
    Yin, C. X.
    Zhong, Q. X.
    Yu, G. P.
    Li, X. D.
    Meng, F. Y.
    NEOPLASMA, 2015, 62 (06) : 864 - 871
  • [33] MOLECULAR DIVERSITY IN AML1/ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(821) POSITIVE ACUTE MYELOID-LEUKEMIA
    VANDELOCHT, LTF
    SMETSERS, TFCM
    WITTEBOL, S
    RAYMAKERS, RAP
    MENSINK, EJBM
    LEUKEMIA, 1994, 8 (10) : 1780 - 1784
  • [34] AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
    Gardini, Alessandro
    Cesaroni, Matteo
    Luzi, Lucilla
    Okumura, Akiko J.
    Biggs, Joseph R.
    Minardi, Simone P.
    Venturini, Elisa
    Zhang, Dong-Er
    Pelicci, Pier Giuseppe
    Alcalay, Myriam
    PLOS GENETICS, 2008, 4 (11):
  • [35] Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells
    Barbetti, Valentina
    Gozzini, Antonella
    Cheloni, Giulia
    Marzi, Ilaria
    Fabiani, Emiliano
    Santini, Valeria
    Dello Sbarba, Persio
    Rovida, Elisabetta
    EPIGENETICS, 2013, 8 (02) : 210 - 219
  • [36] DETECTION OF DNA REARRANGEMENTS IN THE AML1 AND ETO LOCI AND OF AN AML1/ETO FUSION MESSENGER-RNA IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA
    NUCIFORA, G
    BIRN, DJ
    ERICKSON, P
    GAO, JZ
    LEBEAU, MM
    DRABKIN, HA
    ROWLEY, JD
    BLOOD, 1993, 81 (04) : 883 - 888
  • [37] Demonstration of physical and functional interactions of AML1 and AML1/ETO with an ETS protein, MEF.
    Mao, S
    Miyazaki, Y
    Zhang, J
    Nimer, SD
    BLOOD, 1997, 90 (10) : 180 - 180
  • [38] THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFβ/MYH11 POSITIVE AML PATIENTS
    Markova, J.
    Michkova, P.
    Maaloufova, J. Soukupova
    Soukup, P.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2012, 97 : 273 - 274
  • [39] Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia
    Li, Yizhen
    Wang, Huanwei
    Wang, Xiaoling
    Jin, Wen
    Tan, Yun
    Fang, Hai
    Chen, Saijuan
    Chen, Zhu
    Wang, Kankan
    BLOOD, 2016, 127 (02) : 233 - 242
  • [40] Olaparib combined with low-dose chemotherapy for relapsed AML1::ETO positive acute myeloid leukemia in elderly patient
    Lin, Li
    Xue, Song
    Chen, Jiaqi
    Gu, Cuihong
    Zhang, Jingzheng
    Xing, Enhong
    Wang, Wei
    Wang, Lihong
    Zhang, Zhihua
    LEUKEMIA & LYMPHOMA, 2024, 65 (08) : 1181 - 1185
12345